Skip to content
Open access

The changing epidemiology of infection-associated mortality in Alzheimer’s disease in the United States, 1999–2024

Jul 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 48 references
Medicine

TL;DR

Although infection-associated AD mortality declined substantially, a growing genitourinary infection burden widened across sex, rural, and racial strata, with trend-continuation projections suggesting a possible further increase, particularly over the near-term horizon.

Abstract

Background Infections are major immediate causes of death in patients with Alzheimer’s disease, trends across infection subtypes remain poorly characterized. We examined temporal trends, demographic geographic disparities, COVID-19-era patterns, projected infection-associated mortality in United States, 1999–2024. Methods Using CDC Multiple Cause of Death database, infection-associated AD deaths were classified into six subtypes. AAMRs and temporal trends were estimated using joinpoint regression. Kitagawa decomposition assessed demographic age-specific contributions to sex disparities, Bayesian Structural Time Series models projected burden through 2034. Results Among 2,342,153 AD-related deaths, 308,045 (13.2%) were infection-associated. Overall infection-associated AAMR declined by 57.6% (AAPC −3.72% per year), diverging from rising AD mortality. Respiratory infections showed the steepest decline (AAMR −68.3%) with improvements across all regions and urbanization strata. By contrast, genitourinary infections were the only subtype with rising burden—absolute deaths increased 75.1%, rural AAMR rose 73.1% over 1999–2020, and central trend-continuation projections suggest a possible further increase, particularly over the near-term horizon, although uncertainty becomes substantial in the longer term. Kitagawa decomposition showed that the female excess in genitourinary mortality was attributable to higher age-specific female rates rather than to population age structure—uniquely among the subtypes examined (cumulative risk effect +11,337; 47.4% of the female excess; cumulative female deaths exceeding male by 170%); the increase in this risk component over time was directionally consistent but of model-dependent statistical significance. Mortality was overwhelmingly concentrated in the oldest age stratum ( ≥ 85-year rate 2,516-fold that of < 65 years). During the COVID-19 era, overall infection-associated AD mortality fell below pre-pandemic projections, with genitourinary infections showing the smallest cumulative deficit of any subtype. Hispanic individuals had the highest AAMR by 2024, while Non-Hispanic Black individuals maintained elevated septicemia mortality throughout. Conclusion Although infection-associated AD mortality declined substantially, a growing genitourinary infection burden widened across sex, rural, and racial strata, with trend-continuation projections suggesting a possible further increase, particularly over the near-term horizon. These findings, combined with external clinical evidence on infection prevention, suggest that targeted measures—including CAUTI prevention, sex-specific bladder health programs, and rural infection prevention investment—merit priority attention as baby boomers enter peak AD risk.

Read PDF

Similar papers

Sep 2026

Trends in mortality of Alzheimer's disease with comorbid hypertension in patients in the US from 1999-2020.

AIMS To examine temporal trends and demographic disparities in Alzheimer's disease (AD)-related mortality among adults aged ≥ 65 years with comorbid hypertension in the United States from 1999 to 2020. MATERIALS AND METHODS We conducted a population-based retrospective analysis using the Centers for Disease Control a...

S. Shahbaz, Muhammad Hassan Shahbaz, Rauha Fatima et al. · 0 citations
Open access Oct 2026

Temporal trends and demographic disparities in mortality with co-mention of chronic liver disease and pneumonia in the United States, 1999–2024

Chronic liver disease is associated with immune dysfunction and increased susceptibility to pneumonia, yet national mortality trends involving both conditions remain poorly characterized. We examined temporal trends and demographic disparities in mortality with co-mention of chronic liver disease and pneumonia in the U...

Abdul Moeez Awais, Vishan Das, Muhammad Wassam et al. · 0 citations
Open access Sep 2026

Mortality trends and disparities in older U.S. adults with coexisting chronic obstructive pulmonary disease and Alzheimer’s disease, 1999—2023

Objective: Chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease (AD) are leading causes of death among older adults. Their coexistence complicates clinical management and increases disease burden; however, long-term national mortality trends for this comorbidity remain poorly characterized. Methodology:...

Yue-Ming Shu, Feng-Hao Yang · 0 citations
Open access Jun 2026

Rheumatoid Arthritis-Associated Interstitial Lung Disease Mortality Trends in the United States: A Population-Based Analysis (1999–2020)

Objective: To evaluate long term trends and demographic, racial, and geographic disparities in mortality related to rheumatoid arthritis associated interstitial lung disease (RA-ILD) in the United States from 1999 to 2020. Methods: Mortality data were taken from the CDC WONDER Multiple Cause of Death database for indiv...

Farheen Malik, J. Ahmed, M. Shah et al. · 0 citations
Open access Aug 2026

The unequal burden of interstitial lung disease mortality in older US adults: a 22-year analysis and projections to 2030

Introduction Interstitial lung disease (ILD) comprises a heterogeneous group of disorders characterized by progressive lung fibrosis, respiratory failure, and substantial mortality, particularly among older adults. While prior studies have described historical ILD mortality trends, comprehensive analyses incorporating...

Tong Feng, Peng-Cheng Zheng, Yue Cao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.